2021 Kidney Disease Obesity 
Cardiometabolic Health Congress
JULY 25, 2024
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. Ferdinand, MD , ‘Boston Magazine’s 2021 Top Doctor’ Deepak L. The future of care demands a holistic approach.
Journal of the American Heart Association
MARCH 27, 2025
years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Hierarchical clustering of 15 medical conditions was performed to derive multimorbidity patterns. The primary outcome was a composite of inhospital adverse events.
Cardiometabolic Health Congress
OCTOBER 26, 2023
A session at the 18 th Annual Cardiometabolic Health Congress (CMHC), explored the intersection of cardiometabolic conditions such as obesity and insulin resistance with liver disease, beginning with some important new updates on the preferred terms for these diseases. Nonalcoholic fatty liver disease (NAFLD) & NASH.
European Journal of Heart Failure
DECEMBER 22, 2023
Methods and Results Patients with HF from the Swedish HF Registry between 2000-2021 were included. 1.65), chronic kidney disease (HR 1.37, 95%CI 1.34-1.41), 1.41), chronic obstructive pulmonary disease (HR 1.32, 95%CI 1.28-1.35). Obesity was associated with a lower risk of all-cause death (HR 0.81, 95%CI 0.79-0.84).
DAIC
JANUARY 23, 2024
11 Despite the link between inflammation and cardiovascular disease has been proven by extensive research, most physicians have focused on treating high-risk patients with lipid lowering therapies including statin therapy.1,12,13 2021 Apr 20;77(15):1958-1959]. 34 The safety of colchicine, 0.5 μ/L on 0.6 J Am Coll Cardiol. link] 4.
Expert insights. Personalized for you.
100 
Let's personalize your content